Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP1 study of oxytocin secretion in hypopituitarism
2020-004115-27Phase 2Active
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Sep 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of exenatide in hypopituitarism (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoints: Baseline oxytocin concentration, Serial oxytocin concentrations and 6 more. Started Sep 2021; status: active.
02
Drugs
exenatide
03
Conditions
hypopituitarism
Beyond the preview
Go deeper on 2020-004115-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004115-27.